Johns Hopkins Psychiatry Guide
Memantine
DRUG CLASS
- N-methyl–D-aspartate (NMDA) receptor antagonist
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: April 4, 2020
Citation
Barany, E. A. "Memantine." Johns Hopkins Psychiatry Guide, 2020. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787356/all/Memantine.
Barany EA. Memantine. Johns Hopkins Psychiatry Guide. 2020. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787356/all/Memantine. Accessed September 27, 2023.
Barany, E. A. (2020). Memantine. In Johns Hopkins Psychiatry Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787356/all/Memantine
Barany EA. Memantine [Internet]. In: Johns Hopkins Psychiatry Guide. ; 2020. [cited 2023 September 27]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787356/all/Memantine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Memantine
ID - 787356
A1 - Barany,E. ,Pharm.D.
Y1 - 2020/04/04/
BT - Johns Hopkins Psychiatry Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787356/all/Memantine
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
